These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11813176)

  • 1. Significance of intratumoral genetic heterogeneity in neuroblastomas.
    Brodeur GM
    Med Pediatr Oncol; 2002 Feb; 38(2):112-3. PubMed ID: 11813176
    [No Abstract]   [Full Text] [Related]  

  • 2. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity on chromosome 14 in neuroblastoma.
    Suzuki T; Mugishima H; Fujisawa T; Okuni M; Okabe I; Yokota J; Terada M
    Prog Clin Biol Res; 1991; 366():135-45. PubMed ID: 2068134
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
    Tsuchida Y; Hemmi H; Inoue A; Obana K; Yang HW; Hayashi Y; Kanda N; Shimatake H
    Tumour Biol; 1996; 17(2):65-74. PubMed ID: 8658015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
    Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
    Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B
    Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroblastoma with focal MYCN amplification and bone marrow infiltration: a staging and treatment dilemma.
    Kerbl R; Ambros IM; Ambros PF; Lackner H; Dornbusch HJ; Urban CE
    Med Pediatr Oncol; 2002 Feb; 38(2):109-11. PubMed ID: 11813175
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.
    Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; O'Meara A; Ryan E; Catchpoole D; Breatnach F
    Cytogenet Genome Res; 2004; 106(1):49-54. PubMed ID: 15218241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
    Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
    Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human neuroblastoma: amplification of the N-myc oncogene and loss of a putative cancer-preventing gene on chromosome 1p.
    Schwab M
    Recent Results Cancer Res; 1994; 135():7-16. PubMed ID: 8047699
    [No Abstract]   [Full Text] [Related]  

  • 11. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas.
    Ambros PF; Ambros IM; Kerbl R; Luegmayr A; Rumpler S; Ladenstein R; Amann G; Kovar H; Horcher E; De Bernardi B; Michon J; Gadner H
    Med Pediatr Oncol; 2001 Jan; 36(1):1-4. PubMed ID: 11464855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
    Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
    Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR.
    Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P
    Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
    Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and metabolic aspects of neuroblastomas in children under one year of age.
    Nakagawara A; Zaizen Y; Suita S
    Prog Clin Biol Res; 1991; 366():115-25. PubMed ID: 2068132
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroblastoma and the clinical significance of N-myc oncogene amplification.
    Phillips WS; Stafford PW; Duvol-Arnold B; Ghosh BC
    Surg Gynecol Obstet; 1991 Jan; 172(1):73-80. PubMed ID: 1985349
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas.
    Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Iwai J; Shirasawa H; Simizu B
    Cancer Res; 1991 Jun; 51(12):3148-52. PubMed ID: 2039993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T
    Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
    Bown N; Cotterill S; Lastowska M; O'Neill S; Pearson AD; Plantaz D; Meddeb M; Danglot G; Brinkschmidt C; Christiansen H; Laureys G; Speleman F; Nicholson J; Bernheim A; Betts DR; Vandesompele J; Van Roy N
    N Engl J Med; 1999 Jun; 340(25):1954-61. PubMed ID: 10379019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYCN gain and MYCN amplification in a stage 4S neuroblastoma.
    Noguera R; Cañete A; Pellín A; Ruiz A; Tasso M; Navarro S; Castel V; Llombart-Bosch A
    Cancer Genet Cytogenet; 2003 Jan; 140(2):157-61. PubMed ID: 12645655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.